Developing Novel Lyme Treatment

Support Future Events

Help keep these events free to the public.

About the Event

This webinar will discuss the process of a researcher working to discover a novel drug for treating active Lyme disease. The goal of this talk is to define the methods used to identify a new drug, recognize the complexities involved in developing a new drug for infectious disease in general, and provide clarity on the future of treatment for active Lyme disease.

About the Guests

Dr. Timothy Haystead is a Professor of Pharmacology and Cancer Biology at Duke University School of Medicine. His current research is focused on the use of chemical biology approaches to define novel drug targets. These drug targets are focused on the treatment of hypertension, obesity, cancer, inflammatory and infectious disease. Dr. Haystead received his Ph.D. from the University of Dundee, Scotland and he completed post-doctoral work in pharmacology at the Howard Hughes Medical Institute, University of Washington, Seattle. In 2022 Project Lyme provided a $68,170 grant to Bay Area Lyme that supports his Lyme disease research at Duke in honor of Neil Spector.

About the Sponsors

Project Lyme

Our mission is to eradicate the epidemic of tick-borne diseases through awareness and education, support of cutting-edge science, and advocacy for solutions to end the suffering. As a national Lyme disease non-profit, we aim to positively impact patients’ lives through our work.